'Exciting' Lung Cancer Drug Approved for CDF - Medscape

'Exciting' Lung Cancer Drug Approved for CDF  Medscape

Approval for CDF inclusion of 'exciting' immunotherapy drug durvalumab for some lung cancer patients was among this week's announcements by NICE.